Northeast GI Oncology Congress 2026: Bringing the GI Oncology Community Together
Oct 06, 2026
View online
Northeast GI Oncology Congress 2026: Bringing the GI Oncology Community Together
Taiho Oncology Announced Positive Phase 3 Trial Results for Azacitidine and Cedazuridine in MDS and CMML
New Article in ACS’s Flagship Journal Highlights Preventable Cancer Disparities Among Hispanic and Latino People in the US
10 Must-Read Posts In GI Oncology This Week
Phase 3 RASolute 309 Trial Begins: RASONQUE Plus Zoldonrasib in First-Line RAS G12D PDAC
Breast Cancer Treatment in 2026: Precision Is Expanding While Surgery and Radiation Become More Selective
Snooki Is Cancer-Free After Stage 1 Cervical Cancer: Her Diagnosis, Hysterectomy and Recovery
NIH Kids First Program: Genomic Research on Childhood Cancers and Congenital Anomalies
FY26 Breast Cancer Research Program Breakthrough Award: Levels 1 and 2
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
